37 related articles for article (PubMed ID: 23098818)
1. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.
Haduch A; Danek PJ; Kuban W; Pukło R; Alenina N; Gołębiowska J; Popik P; Bader M; Daniel WA
Neurochem Int; 2022 Jan; 152():105223. PubMed ID: 34780807
[TBL] [Abstract][Full Text] [Related]
3. Potential role of CYP2D6 in the central nervous system.
Cheng J; Zhen Y; Miksys S; Beyoğlu D; Krausz KW; Tyndale RF; Yu A; Idle JR; Gonzalez FJ
Xenobiotica; 2013 Nov; 43(11):973-84. PubMed ID: 23614566
[TBL] [Abstract][Full Text] [Related]
4. The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism.
Haduch A; Bromek E; Kuban W; Daniel WA
Metabolites; 2023 May; 13(5):. PubMed ID: 37233670
[TBL] [Abstract][Full Text] [Related]
5. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
[TBL] [Abstract][Full Text] [Related]
6. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances.
Sheng Y; Yang H; Wu T; Zhu L; Liu L; Liu X
Front Pharmacol; 2021; 12():650027. PubMed ID: 33967789
[TBL] [Abstract][Full Text] [Related]
7. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
[TBL] [Abstract][Full Text] [Related]
8. Prenatal Exposure of Cypermethrin Induces Similar Alterations in Xenobiotic-Metabolizing Cytochrome P450s and Rate-Limiting Enzymes of Neurotransmitter Synthesis in Brain Regions of Rat Offsprings During Postnatal Development.
Singh A; Mudawal A; Maurya P; Jain R; Nair S; Shukla RK; Yadav S; Singh D; Khanna VK; Chaturvedi RK; Mudiam MKR; Sethumadhavan R; Siddiqi MI; Parmar D
Mol Neurobiol; 2016 Aug; 53(6):3670-3689. PubMed ID: 26115703
[TBL] [Abstract][Full Text] [Related]
9. The Energy Metabolism in Caenorhabditis elegans under The Extremely Low-Frequency Electromagnetic Field Exposure.
Shi Z; Yu H; Sun Y; Yang C; Lian H; Cai P
Sci Rep; 2015 Feb; 5():8471. PubMed ID: 25683579
[TBL] [Abstract][Full Text] [Related]
10. Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors.
Singh A; Mudawal A; Shukla RK; Yadav S; Khanna VK; Sethumadhavan R; Parmar D
Mol Neurobiol; 2015 Aug; 52(1):741-56. PubMed ID: 25288152
[TBL] [Abstract][Full Text] [Related]
11. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.
Miller RT; Miksys S; Hoffmann E; Tyndale RF
Br J Pharmacol; 2014 Jun; 171(12):3077-88. PubMed ID: 24611668
[TBL] [Abstract][Full Text] [Related]
12. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.
Haduch A; Bromek E; Kot M; Kamińska K; Gołembiowska K; Daniel WA
J Neurochem; 2015 Apr; 133(1):83-92. PubMed ID: 25581337
[TBL] [Abstract][Full Text] [Related]
13. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
14. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Yu AM; Idle JR; Byrd LG; Krausz KW; Küpfer A; Gonzalez FJ
Pharmacogenetics; 2003 Mar; 13(3):173-81. PubMed ID: 12618595
[TBL] [Abstract][Full Text] [Related]
15. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters.
Anna Haduch A; Bromek E; Daniel WA
Pharmacol Rep; 2013; 65(6):1519-28. PubMed ID: 24553000
[TBL] [Abstract][Full Text] [Related]
16. Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?
Ozdemir V; Gunes A; Dahl ML; Scordo MG; Williams-Jones B; Someya T
Pharmacogenomics; 2006 Dec; 7(8):1199-210. PubMed ID: 17184207
[TBL] [Abstract][Full Text] [Related]
17. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.
Haduch A; Bromek E; Sadakierska-Chudy A; Wójcikowski J; Daniel WA
Pharmacol Res; 2013 Jan; 67(1):53-9. PubMed ID: 23098818
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
